KRM Ayurveda IPO

About KRM Ayurveda IPO

The offer consists of a fresh issue component. The fresh issue will include 0.57 crore shares of ₹77.49 crore. The total number of shares is 57,40,000 shares (aggregating up to ₹77 crores).

The KRM Ayurveda IPO opens on Monday, Jan 21, 2026 and closes on Wednesday, Jan 21, 2026. The allotment of shares will take place on Thursday, Jan 27, 2026. The credit of shares to the demat account will take place on Friday, Jan 23, 2026. The initiation of refunds will take place on Friday, Jan 23, 2026. The listing of shares will take place on Tuesday, Jan 27, 2026.

KRM Ayurveda focuses on medication that is based on the fundamental ideology of Ayurveda. They have their own medicine processing unit in Kundli, Haryana. This unit formulates Ayurvedic classical and proprietary medicines and nutraceuticals. Their comprehensive product range includes capsules, tablets, syrups, gels, oils and powders, catering to diverse healthcare needs with efficiency and precision.

Objectives of KRM Ayurveda

• Capital expenditure for the construction and development of telemedicine operational facilities.
• Purchase of CRM software and hardware infrastructure.
• Human resources.
• Repayment/prepayment of loan.
• To meet the working capital requirements of the company.
• To meet the general corporate purposes.

Industry Outlook

The AYUSH sector in India has grown significantly in recent years, becoming an important part of the country's economy and job market. AYUSH includes traditional forms of medicine such as Ayurveda, Yoga, Unani, Siddha, and Homeopathy. This sector encompasses hospitals, clinics, wellness centres, research, herbal products, education, and holistic health practices. This growth is driven by greater awareness, the rising demand for natural therapies, and government support for traditional medicine.

India’s strong tradition of ancient healing practices and the large number of trained practitioners make AYUSH treatments popular. The AYUSH market in India has seen remarkable growth, skyrocketing from US$285 crores in 2014 to US$2,400 crores in 2024.

KRM Ayurveda Company Information

KRM Ayurveda, established in 2019, operates a network of hospitals and clinics across multiple cities in India and has also marked its presence abroad through telemedicine consulting and sales. They integrate authentic Ayurvedic wisdom with modern practices to address chronic, lifestyle, and preventive health needs through personalised care and wellness programmes. Presently, they run 6 (six) hospitals and 5 (five) clinics at different locations in the country.

Though KRM Ayurveda started off as a kidney hospital and it continues to provide specialised treatment for kidney disorders, they have widened their horizons in the past few years and have now evolved to treat various health disorders such as kidney disorders, liver cirrhosis, diabetes, fatty liver, arthritis, etc. They have also marked their reach globally through tele-consultancy services.

Strengths of KRM Ayurveda

• Expertise in Ayurveda and Holistic Wellness.
• Customized diet and lifestyle plans.
• Commitment to ayurvedic awareness and education.
• Skilled Ayurvedic physicians and certified therapists ensure treatment quality.
• Centralised GMP-certified production of Ayurvedic medicines ensures purity and efficacy.

Risks of KRM Ayurveda

• Any disruption from third-party transportation providers for the supply of raw materials and finished products.
• The illegal distribution and sale by third parties of counterfeit versions of their products.
• Any manufacturing or quality control problems.
• Significant competition from local and regional players in the business segments and geographical markets in which they operate.
• Financial instability in other countries that may cause increased volatility in Indian and other financial markets.

Note:
Industry Peer may be modified for finalization of Issue Price before filing Red Herring Prospectus with ROC.
*Sourced from Yearly Audited Financials/ Annual reports
*RONW (%) and NAV (Rs. per share) for the peer companies have been calculated as per the half yearly unaudited financials.

Notes:

• Considering the nature and turnover of business of the Company, the peers are not strictly comparable. However, the same have been included for broader comparison.
• The figures for KRM Ayurveda are based on the restated results for the period ended September 30, 2025.
• The figures for the peer group are based on standalone unaudited results for the period ended September 30 2025.
• Current Market Price (CMP) is the closing price of respective scrip as on December 31, 2025.

Anchor Investor Bidding Date: January 20, 2026*
*The company in consultation with the BRLM, have considered participation by Anchor Investors in accordance with the SEBI ICDR Regulations. The Anchor Investor Bidding Date shall be one working day prior to the Issue Opening Date.

Registrar: Skyline Financial Services Private Limited
Book Running Lead Managers: NEXGEN Financial Solutions Pvt. Ltd.

KRM Ayurveda Business Model

The company earns its revenue through the following: Operating a network of hospitals and clinics across multiple cities in India along with telemedicine consulting and sales. They integrate authentic Ayurvedic wisdom with modern practices to address chronic, lifestyle, and preventive health needs through personalised care and wellness programmes.

KRM Ayurveda Growth Trajectory

(Restated Data) KRM Ayurveda’s total income for FY25 stood at ₹76.95 crores, whereas in FY24 it was ₹67.57 crores, representing an increase of 13.88%.

The revenue from operations for FY25 stood at ₹76.55 crores, whereas in FY24 it was ₹67.16 crores, representing an increase of 13.99%.

The profit after tax for the period ended 31 March 2025 stood at ₹12.13 crores, and for the year ended 31 March 2024 it was ₹3.41 crores, representing an increase of 255.20%.

Their EBITDA increased from ₹7.34 crores in FY24 to ₹19.11 crores in FY25.

KRM Ayurveda Market Position

Presently, the company has 6 (Six) Hospitals at different locations in the country. Their hospitals are empanelled with ECHS and CGHS Schemes. Their Hospitals have also tied up with companies and health insurance providers to offer cashless treatment. The company runs 5 (Five) Clinics at different locations in the country.

As of 31 March 2025, the company’s Total Income, Profit After Tax, and EBITDA were ₹76.950 crores, ₹12.097 crores, and ₹19.109 crores, respectively.

How to apply for KRM Ayurveda IPO?

• Step 1: Log in to your Kotak Securities Demat account - Log in to your Demat account to access IPO investments. Next, select the current IPO section.
• Step 2: Specify IPO details - Enter the number of lots and the price you wish to apply for.
• Step 3: Enter UPI ID - After entering your UPI ID, click submit. This will place your bid with the exchange.
• Step 4: Mandate Notification - Your UPI app will receive a mandate notification to block funds.
• Step 5: Approve Request - Your funds will be blocked once you approve the mandate request on your UPI.